Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium
NCT04060017Phase 2Active, not recruiting
- Sponsor
- Southwest Autism Research & Resource Center
- Start
- Sep 2020
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of levoleucovorin in Autism Spectrum Disorder (ASD), language disorder, sponsored by Southwest Autism Research & Resource Center. Started Sep 2020; status: active, not recruiting.
02
Drugs
levoleucovorin
03
Conditions
Autism Spectrum Disorder (ASD)language disorder
Beyond the preview
Go deeper on NCT04060017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04060017.